lymphoproliferative disorders comparison between 2 prospective studies in patients with Nonmyeloablative transplantation with or without alemtuzumab
暂无分享，去创建一个
J. Miguel | C. Craddock | D. Linch | R. Chopra | R. Martino | A. Goldstone | K. Yong | D. Milligan | A. Parker | P. Kottaridis | S. Schey | A. León | A. Pérez-Simón | Stephen Mackinnon Urbano-Ispizua | J. Garcí | Panagiotis D. Kottaridis